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Background: Highly-active anti-retroviral therapy (HAART) for Human Immunodeficiency Virus (HIV) infection is associated with metabolic 
abnormalities including dyslipidemia, hyperglycemia, and increased risk of cardiovascular disease. We hypothesized that HIV patients on HAART 
would have increased intra-myocardial triglyceride accumulation (cardiac steatosis), as well as left ventricular dysfunction secondary to HAART 
exposure.
Methods: This prospective study examined 27 HIV+ subjects and 22 HIV(-) age-matched controls. Inclusion criteria included males 35-55 years 
of age, and on HAART for ≥ 3 years. Exclusion criteria included known cardiovascular disease, smoking/drug history, diabetes, or current AIDS-
defining diseases. We compared both groups in regards to medical history, physical exam and laboratory findings; the two groups underwent cardiac 
magnetic resonance imaging and spectroscopy for determination of LV morphology, function, coronary stenosis, and myocardial triglyceride content, 
respectively.
results: Neither LV mass (HIV+: 107.3 + 20.8 g; HIV-: 109.3 + 23.0 g) nor LV ejection fraction (HIV+: 62 + 6%; HIV-: 61 + 4%) differed between 
HIV+ and HIV(-) subjects. In contrast, MR tissue tagging revealed subclinical LV systolic (circumferential strain; HIV+: -18.8 + 0.5%; HIV-: -20.8 + 
0.4%; P < 0.01) and diastolic dysfunction (circumferential strain rate; HIV+: 154.4 + 5.5; HIV-:189.6 + 9.0; P < 0.01) in HIV+ subjects. Likewise, 
MR spectroscopy revealed a three-fold elevation in myocardial triglyceride content in cases compared to controls (0.86 + 0.02 vs. 0.27 + 0.06, 
respectively; P = 0.05). Both LV dysfunction and cardiac steatosis were strongly related to duration of HAART exposure.
conclusions: Our MRI data reveal derangements in both LV function and metabolism in asymptomatic, otherwise healthy, HIV+ subjects on HAART. 
These derangements were independently predicted by HAART exposure, supporting the hypothesis that HAART exposure contributes to myocardial 
decline. 
